215 related articles for article (PubMed ID: 21915479)
21. Revision endoscopic orbital decompression in the management of Graves' orbitopathy.
Leung MK; Platt MP; Metson R
Otolaryngol Head Neck Surg; 2009 Jul; 141(1):46-51. PubMed ID: 19559957
[TBL] [Abstract][Full Text] [Related]
22. Clinical and radiological characteristics of Graves' orbitopathy patients showing spontaneous decompression.
Kang EM; Yoon JS
J Craniomaxillofac Surg; 2015 Jan; 43(1):48-52. PubMed ID: 25457466
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of globe subluxation in the active phase of the myogenic type of Graves orbitopathy: case reports.
Eing F; Cruz AA
Arq Bras Oftalmol; 2012; 75(2):131-3. PubMed ID: 22760806
[TBL] [Abstract][Full Text] [Related]
24. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.
Gonçalves AC; Silva LN; Gebrim EM; Matayoshi S; Monteiro ML
Clinics (Sao Paulo); 2012 Aug; 67(8):891-6. PubMed ID: 22948455
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and complications of orbital fat decompression in Graves' orbitopathy: a systematic review and meta-analysis.
Willaert R; Maly T; Ninclaus V; Huvenne W; Vermeersch H; Brusselaers N
Int J Oral Maxillofac Surg; 2020 Apr; 49(4):496-504. PubMed ID: 31474503
[TBL] [Abstract][Full Text] [Related]
26. Natural history of graves' orbitopathy after treatment.
Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
[TBL] [Abstract][Full Text] [Related]
27. Orbital decompression in Graves' orbitopathy: efficacy and safety.
Goh MS; McNab AA
Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the retrobulbar space in Graves' orbitopathy using color Doppler ultrasonography].
Cmelo J; Chynoranský M; Zvác J; Rybár M
Cesk Slov Oftalmol; 1997 May; 53(2):106-11. PubMed ID: 9296857
[TBL] [Abstract][Full Text] [Related]
29. Modified lateral orbital wall decompression in Graves' orbitopathy using computer-assisted planning.
Spalthoff S; Jehn P; Zimmerer R; Rana M; Gellrich NC; Dittmann J
Int J Oral Maxillofac Surg; 2018 Feb; 47(2):167-174. PubMed ID: 29096933
[TBL] [Abstract][Full Text] [Related]
30. Classification of orbital morphology for decompression surgery in Graves' orbitopathy: two-dimensional versus three-dimensional orbital parameters.
Borumandi F; Hammer B; Noser H; Kamer L
Br J Ophthalmol; 2013 May; 97(5):659-62. PubMed ID: 23428985
[TBL] [Abstract][Full Text] [Related]
31. Computer aided volumetric assessment of orbital structures in patients with Graves' orbitopathy: correlation with serum thyroid antiperoxidase antibodies and disease activity.
Paniagua L; Bande MF; Abalo-Lojo JM; Gonzalez F
Int Ophthalmol; 2023 Sep; 43(9):3377-3384. PubMed ID: 37338774
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and side effects of 'swinging eyelid' orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia.
Paridaens D; Lie A; Grootendorst RJ; van den Bosch WA
Eye (Lond); 2006 Feb; 20(2):154-62. PubMed ID: 15746952
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter.
Walasik-Szemplińska D; Kamiński G; Mańczak M; Widłak J; Sudoł-Szopińska I
Front Endocrinol (Lausanne); 2019; 10():707. PubMed ID: 31681176
[No Abstract] [Full Text] [Related]
34. Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy.
Abdel Razek AA; El-Hadidy M; Moawad ME; El-Metwaly N; El-Said AA
Neuroradiol J; 2017 Jun; 30(3):230-234. PubMed ID: 28379055
[TBL] [Abstract][Full Text] [Related]
35. The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry.
Đorić I; Žarković M; Radojičić Z; Repac N; Janićijević A; Rotim K; Tasić G; Rasulić L
Acta Clin Croat; 2017 Mar; 56(1):21-27. PubMed ID: 29120123
[TBL] [Abstract][Full Text] [Related]
36. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the eyebrow fat pad in Graves' orbitopathy.
Goldberger S; Sarraf D; Bernstein JM; Hurwitz JJ
Ophthalmic Plast Reconstr Surg; 1994 Jun; 10(2):80-6. PubMed ID: 8086367
[TBL] [Abstract][Full Text] [Related]
38. Orbital and ocular perfusion in thyroid eye disease.
Goel R; Shah S; Sundar G; Arora R; Gupta S; Khullar T
Surv Ophthalmol; 2023; 68(3):481-506. PubMed ID: 36681278
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the superior orbital vein using color doppler ultrasonography].
Cmelo J; Zvác J
Cesk Slov Oftalmol; 1996 Nov; 52(6):379-86. PubMed ID: 9072214
[TBL] [Abstract][Full Text] [Related]
40. Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.
Perros P; Žarković MP; Panagiotou GC; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi AM; Nardi M; Brix TH; Covelli D; Daumerie C; Eckstein AK; Fichter N; Ćirić S; Hegedüs L; Kahaly GJ; Konuk O; Lareida JJ; Okosieme OE; Leo M; Mathiopoulou L; Clarke L; Menconi F; Morris DS; Orgiazzi J; Pitz S; Salvi M; Muller I; Knežević M; Wiersinga WM; Currò N; Dayan CM; Marcocci C; Marinò M; Möller L; Pearce SH; Törüner F; Bernard M;
J Endocrinol Invest; 2020 Dec; 43(12):1717-1722. PubMed ID: 32474767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
